Merck's KEYTRUDA® Significantly Improved Overall Survival Versus Placebo in Certain Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib Pharmaceutical Investing
Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday, February 1, 2022 Pharmaceutical Investing
Applied UV Continues to Expand Intellectual Portfolio with Additional Patent Grant Medical Device Investing
Bloom Health Partners Announces Contract With State of Texas For K-12 Schools Medical Device Investing
Merck Animal Health's Third Veterinarian Wellbeing Study Reveals Increased Health Challenges and Psychological Distress Among Veterinarians Life Science Investing
BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics Data for BETR-001 Pharmaceutical Investing
Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation Pharmaceutical Investing
Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine Pharmaceutical Investing
Sirona Biochem Renews Agreement with CURE Intelligence for Marketing and Communications Support Life Science Investing
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
